To include your compound in the COVID-19 Resource Center, submit it here.

Teva, Momenta, Mylan, Natco, Novartis autoimmune, generics news

The U.S. District Court for the Southern District of New York denied a motion by Teva for summary judgment of no inequitable conduct in its ongoing case seeking to block

Read the full 304 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE